Advertisement

Clinical management of acute myocarditis and cardiomyopathy

  • Kenneth L. Baughman
Part of the Progress in Inflammation Research book series (PIR)

Abstract

Several forms of acute myocarditis may present as new onset cardiomyopathy and congestive heart failure. These include myocarditis characterized as fulminant, giant cell, chronic acute, eosinophilic (particularly necrotizing eosinophilic myocarditis), peripartum, Lyme, small pox vaccine related, HIV-related, and acute myocardial infarction caused by myocarditis with coronary arteritis. Treatment of each of these disorders is dependent upon considering the diagnosis, performing endomyocardial biopsy for histologic confirmation, and use of immune modulating or immunosuppressive therapy in appropriate candidates. Some forms of acute myocarditis may resolve spontaneously without any treatment including fulminant myocarditis, peripartum, and small pox vaccine related myocarditis. Others require immune modulating therapy including giant cell myocarditis, and eosinophilic myocarditis; while others require specific treatment for the infectious or autoimmune pathogen responsible including eosinophilic myocarditis, Lyme myocarditis, and HIV-related. We currently have the technology which may allow us to determine if the 50% of patients with “idiopathic” cardiomyopathy in fact have a viral or post viral autoimmune related compromise of cardiac function.

Keywords

Dilate Cardiomyopathy Cardiac Sarcoidosis Acute Myocarditis Peripartum Cardiomyopathy Smallpox Vaccination 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Felker GM, Thompson RE, Hare JM, Hruban RH, Clemetson DE, Howard DL, Baughman KL, Kasper EK (2000) Underlying causes and long-term survival in patients with Initially unexplained cardiomyopathy. N Engl J Med 342(15): 1077–1084CrossRefPubMedGoogle Scholar
  2. 2.
    Kühl U, Pauschinger M, Noutsias M, Seeberg B, Bock T, Lassner D, Poller W, Kandolf R, Schultheiss HP (2005) High prevalence of viral genomes and multiple viral infections in the myocardium of adults with “idiopathic” left ventricular dysfunction. Circulation 111(7): 887–893CrossRefPubMedGoogle Scholar
  3. 3.
    Bowles NE, Ni J, Kearney DL, Pauschinger M, Schultheiss HP, McCarthy R, Hare J, Bricker JT, Bowles KR, Towbin JA (2003) Detection of viruses in myocardial tissues by polymerase chain reactions: Evidence of adenovirus as a common cause of myocarditis in children and adults. J Am Coll Cardiol 42: 466–472CrossRefPubMedGoogle Scholar
  4. 4.
    Aretz HT, Billingham ME, Edwards WD, Factor SM, Fallon JT, Fenoglio JJ, Olsen EG, Schoen FJ (1987) Myocarditis. A histopathologic definition and classification. Am J Cardiovasc Pathol 1(1): 3–14PubMedGoogle Scholar
  5. 5.
    Hauck AJ, Kearney DL, Edwards WD (1989) Evaluation of postmortem endomyocardial biopsy specimens from 38 patients with lymphocytic myocarditis: Implications for role of sampling error. Mayo Clinic Proc 64(10): 1235–45Google Scholar
  6. 6.
    Friedrich MG, Strohm O, Schulz-Menger L, Marciniak H, Luft FC, Dietz R (1998) Contrast media-enhanced magnetic resonance imagining visualizes myocardial changes in the course of viral myocarditis. Circulation 97(18): 1802–9PubMedGoogle Scholar
  7. 7.
    Mahrholdt H, Goedecke C, Wagner A, Meinhardt G, Athanasiadis A, Vogelsberg H, Fritz P, Klingel K, Kandolf R, Sechtem U (2004) Cardiovascular magnetic resonance assessment of human myocarditis: A comparison to histology and molecular pathology. Circulation 109(10): 1250–8CrossRefPubMedGoogle Scholar
  8. 8.
    Mason JW, O’Connell JB, Herskowitz A, Rose NR, McManus BM, Billingham ME, Moon TE (1995) A clinical trial of immunosuppressive therapy for myocarditis. N Engl J Med 333(5): 269–275CrossRefPubMedGoogle Scholar
  9. 9.
    Baughman KL (2006) Diagnosis of myocarditis: Death of Dallas criteria. Circulation 113(4): 593–595CrossRefPubMedGoogle Scholar
  10. 10.
    Bowles NE, Ni J, Kearney DL, Pauschinger M, Schultheiss HP, McCarthy R, Hare J, Bricker JT, Bowles KR, Towbin JA (2003) Detection of viruses in myocardial tissues by polymerase chain reaction. Evidence of adenovirus as a common cause of myocarditis in children and adults. J Am Coll Cardiol 42(3): 466–472CrossRefPubMedGoogle Scholar
  11. 11.
    Why HJ, Meany BT, Richardson PJ, Olsen EG, Bowles NE, Cunningham L, Freeke CA, Archard LC (1994) Clinical and prognostic significance of detection of enteroviral RNA in the myocardium of patients with myocarditis or dilated cardiomyopathy. Circulation 89(6): 2582–9PubMedGoogle Scholar
  12. 12.
    Frustaci A, Chimenti C, Calabrese F, Pieroni M, Thiene G, Maseri (2003) Immunosuppressive therapy for active lymphocytic myocarditis: Virological and immunologic profile of responders versus nonresponders. Circulation 107(6): 857–63CrossRefPubMedGoogle Scholar
  13. 13.
    Wojnicz R, Nowalany-Kozielska E, Wojciechowska C, Glanowska G, Wilczewiski P, Niklewski T, Zembala M, Polonski L, Rozek MM, Wodniecki J (2001) Randomized, placebo-controlled study for immunosuppressive treatment of inflammatory dilated cardiomyopathy: Two-year follow-up results. Circulation 104(1): 39–45PubMedGoogle Scholar
  14. 14.
    Deckers JW, Hare JM, Baughman KL (1992) Complications of transvenous right ventricular endomyocardial biopsy in adult patients with cardiomyopathy: A seven-year survey of 546 consecutive diagnostic procedures in a tertiary referral center. J Am Coll Cardiol 19(1): 43–7CrossRefPubMedGoogle Scholar
  15. 15.
    Lieberman EB, Hutchins GM, Herskowitz A, Rose NR, Baughman KL (1991) Clinicopathologic description of myocarditis. J Am Coll Cardiol 18(7): 1617–26CrossRefPubMedGoogle Scholar
  16. 16.
    McCarthy RE, Boehmer JP, Hruban RH, Hutchins GM, Kasper EK, Hare JM, Baughman KL (2000) Long-term outcome of fulminant myocarditis as compared with acute (nonfulminant) myocarditis. N Engl J Med 342(10): 690–695CrossRefPubMedGoogle Scholar
  17. 17.
    Felker GM, Boehmer RH, Hruban GM, Hutchins GM, Kasper EK, Baughman KL, Hare JM (2000) Echocardiographic findings in fulminant and acute myocarditis. J Am Coll Cardiol 36(1): 227–232CrossRefPubMedGoogle Scholar
  18. 18.
    Amabile N, Fraisse A, Bouvenot J, Chetaille P, Ovaert C (2006) Outcome of acute fulminant myocarditis in children. Heart 92(9): 1269–1273CrossRefPubMedGoogle Scholar
  19. 19.
    Cooper LT, Berry GJ, Shabetal R (1997) Idiopathic giant-cell myocarditis — Natural history and treatment. N Engl J Med 336(26): 1860–1866CrossRefPubMedGoogle Scholar
  20. 20.
    Frustaci A, Cuoco L, Chimenti C, Pieroni M, Fioravanti G, Gentiloni N, Maseri A, Gasbarrini G (2002) Celiac disease associated with autoimmune myocarditis. Circulation 105(22): 2611–2618CrossRefPubMedGoogle Scholar
  21. 21.
    Nash CL, Panaccione R, Sutherland LR, Meddings JB (2001) Giant cell myocarditis, in a patient with Crohn’s disease, treated with etanercept — A tumor necrosis factor-alpha antagonist. Can J Gastroenterol 15(9): 607–11PubMedGoogle Scholar
  22. 22.
    Okura Y, Dec GW, Hare JM, Kodama M, Berry GJ, Tazelaar HD, Bailey KR, Cooper LT (2003) A clinical and histopathologic comparison of cardiac sarcoidosis and idiopathic giant cell myocarditis. J Am Coll Cardiol 41(2): 322–9CrossRefPubMedGoogle Scholar
  23. 23.
    Hanawa H, Izumi T, Saito Y, Ochiai Y, Okura Y, Inomata T, Hirono S, Ogawa Y, Saito R, Kodama M et al (1998) Recovery from complete atrioventricular block caused by idiopathic giant cell myocarditis after corticosteroid therapy. Jpn Circ J 62(3): 211–4CrossRefPubMedGoogle Scholar
  24. 24.
    Menghini VV, Savcenko V, Olson LJ, Tazelaar HD, Dec GW, Kao A, Cooper LT (1999) Combined immunosuppression for the therapy of idiopathic giant cell myocarditis. Mayo Clinic Proc 74(12): 1221–1226CrossRefGoogle Scholar
  25. 25.
    Cooper LT (2000) Giant cell myocarditis: Diagnosis and treatment. Herz 25(3): 291–8CrossRefPubMedGoogle Scholar
  26. 26.
    Taliercio CP, Olney BA, Lie JT (1985) Myocarditis related to drug hypersensitivity. Mayo Clinic Proc 60(7): 463–8Google Scholar
  27. 27.
    Spear GS (1995) Eosinophilic explant carditis with eosinophilia: ? hypersensitivity to dobutamine infusion. J Heart Lung Transplant 14(4): 755–60PubMedGoogle Scholar
  28. 28.
    Herzog CA, Snover DC, Staley NA (1984) Acute necrotizing eosinophilic myocarditis. Br Heart J 52(3): 343–8CrossRefPubMedGoogle Scholar
  29. 29.
    Midei MG, DeMent SH, Feldman AM, Hutchins GM, Baughman KL (1990) Peripartum myocarditis and cardiomyopathy. Circulation 81(3): 922–8PubMedGoogle Scholar
  30. 30.
    Sanderson JE, Olsen EG, Gatel D (1986) Peripartum hear disease: An endomyocardial biopsy study. Br Heart J 56(3): 285–91CrossRefPubMedGoogle Scholar
  31. 31.
    Rizeq MN, Rickenbacher PR, Fowler MB, Billingham ME (1994) Incidence of myocarditis in peripartum cardiomyopathy. Am J Cardiol 74(5): 474–7CrossRefPubMedGoogle Scholar
  32. 32.
    O’Connell JB, Costanzo-Nordin MR, Subramanian R, Robinson JA, Wallis DE, Scanlon PJ, Gunnar RM (1986) Peripartum cardiomyopathy: Clinical, hemodynamic, histologic and prognostic characteristics. J Am Coll Cardiol 8(1): 52–6CrossRefPubMedGoogle Scholar
  33. 33.
    Felker GM, Jaeger CJ, Klodas E, Thiemann DR, Hare JM, Hruban RH, Kasper EK, Baughman KL (2000) Myocarditis and long-term survival in peripartum cardiomyopathy. Am Heart J 140(5): 785–91CrossRefPubMedGoogle Scholar
  34. 34.
    Silwa K, Skudicky D, Bergemann A, Candy G, Puren A, Sareli P (2000) Peripartum cardiomyopathy: Analysis of clinical outcome, left ventricular function, plasma levels of cytokines and fas/APO-1. J Am Coll Cardiol 35(3): 701–5CrossRefGoogle Scholar
  35. 35.
    Steere AC (2001) Lyme disease. N Engl J Med 345(2): 115–25CrossRefPubMedGoogle Scholar
  36. 36.
    Steere AC, Batsford WP, Weinberg M, Alexander J, Berger HJ, Wolfson S, Malawista SE (1980) Lyme carditis: Cardiac abnormalities of lyme disease. Ann Intern Med 93(1): 8–16PubMedGoogle Scholar
  37. 37.
    McAlister HF, Klementowicz PT, Andrews C, Fisher JD, Feld M, Furman S (1989) Lyme carditis: An important cause of reversible heart block. Ann Intern Med 110(5): 339–45PubMedGoogle Scholar
  38. 38.
    van der Linde MR, Crijns HJ, de Koning J, Hoogkamp-Korstanje JA, de Graaf JJ, Piers DA, van der Galien A, Lie KI (1990) Range of atrioventricular conduction disturbances in lyme borreliosis: A report of four cases and review of other published reports. Br Heart J 63(3): 162–8CrossRefPubMedGoogle Scholar
  39. 39.
    Stanek G, Klein J, Bittner R, Glogar D (1990) Isolation of Borrelia burgdorferi from the myocardium of a patient with longstanding cardiomyopathy. N Engl J Med 322(4): 249–52CrossRefPubMedGoogle Scholar
  40. 40.
    Dec GW, Waldman H, Southern J, Fallon JT, Hutter AM, Palacios I (1992) Viral myocarditis mimicking acute myocardial infarction. J Am Coll Cardiol 20(1): 85–9CrossRefPubMedGoogle Scholar
  41. 41.
    Sarda L, Colin P, Boccara F, Daou D, Lebtahi R, Faraggi M, Nguyen C, Cohen A, Slama MS, Steg PG, Le Guludec D (2001) Myocarditis in patients with clinical presentation of myocardial infarction and normal coronary angiograms. J Am Coll Cardiol 37(3): 786–92CrossRefPubMedGoogle Scholar
  42. 42.
    Angelini A, Calzolari V, Calabrese F, Boffa GM, Maddalena F, Chioin R, Thiene G (2000) Myocarditis mimicking acute myocardial infarction: Role of endomyocardial biopsy in the differential diagnosis. Heart 84(3): 245–50CrossRefPubMedGoogle Scholar
  43. 43.
    Wang K, Asinger RW, Marriott HJ (2003) ST-segment elevation in conditions other than acute myocardial infarction. N Engl J Med 349(22): 128–35CrossRefGoogle Scholar
  44. 44.
    Klein RM, Schwartzkopff R, Strauer BE (1998) Evidence of endothelial dysfunction of epicardial coronary arteries in patients with immunohistochemically proven myocarditis. Am Heart J 136(3): 389–97CrossRefPubMedGoogle Scholar
  45. 45.
    Centers for Disease Control and Prevention: Morbidity and Mortality Weekly Report (2003) Update: Cardiac related events during the civilian smallpox vaccination program — United States 2003. J Am Med Assoc 290(1): 31–34CrossRefGoogle Scholar
  46. 46.
    Halsell JS, Riddle JR, Atwood JE, Gardner P, Shope R, Poland GA, Gray GC, Ostroff S, Eckart RE, Hospenthal DR, Gibson RL et al (2003) Myopericarditis following smallpox vaccination among vaccinia-naïve U.S. military personnel. J Am Med Assoc 289(24): 3283–3289CrossRefGoogle Scholar
  47. 47.
    Centers for Disease Control and Prevention (2003) Update: Cardiac related events during the civilian smallpox vaccination program — United States. MMWR Morb Mortal Wkly Rep 52(27): 639–42Google Scholar
  48. 48.
    Cassimatis DC, Atwood JE, Engler RM, Linz PE, Grabenstein JD, Vernalis MN (2004) Smallpox vaccination and myopericarditis: A clinical review. J Am Coll Cardiol 43(9): 1503–10CrossRefPubMedGoogle Scholar
  49. 49.
    Eckart RE, Love SS, Atwood JE, Arness MK, Cassimatis DC, Campbell CL, Boyd SY, Murphy JG, Swerdlow DL, Collins LC et al (2004) Incidence and follow-up of inflammatory cardiac complications after smallpox vaccination. J Am Coll Cardiol 44(1): 201–5CrossRefPubMedGoogle Scholar
  50. 50.
    Murphy JG, Wright RS, Bruce GK, Baddour LM, Farrell MA, Edwards WD, Kita H, Cooper LT (2003) Eosinophilic-lympocytic myocarditis after smallpox vaccination. Lancet 362(9393): 1378–80CrossRefPubMedGoogle Scholar
  51. 51.
    Herskowitz A, Vlahov D, Willoughby S, Chaisson RE, Schulman SP, Neumann DA, Baughman KL (1993) Prevalence and incidence of left ventricular dysfunction in patients with human immunodeficiency virus infection. Am J Cardiol 71(11): 955–8CrossRefPubMedGoogle Scholar
  52. 52.
    Barbaro G, Di Lorenzo G, Grisorio B, Barbarini G (1998) Incidence of dilated cardiomyopathy and detection of HIV in myocardial cells of HIV-positive patients. N Engl J Med 339(16): 1093–9CrossRefPubMedGoogle Scholar
  53. 53.
    Herskowitz A, Wu TC, Willoughby SB, Vlahov D, Ansari AA, Beschorner WE, Baughman KL (1994) Myocarditis and cardiotropic viral infection associated with severe left ventricular dysfunction in late-stage infection with human immunodeficiency virus. J Am Coll Cardiol 24(4): 1025–32CrossRefPubMedGoogle Scholar
  54. 54.
    Anderson DW, Virmani R, Reilly JM, O’Leary T, Cunnion RE, Robinowitz M, Macher AM, Punja U, Villaflor ST, Parrillo JE et al (1988) Prevalent myocarditis at necropsy in the acquired immunodeficiency syndrome. J Am Coll Cardiol 11(4): 792–9CrossRefPubMedGoogle Scholar
  55. 55.
    Hofman R, Drici MD, Gibelin P, Michiels JF, Thyss A (1993) Prevalence of toxoplasma myocarditis in patients with the acquired immunodeficiency syndrome. Br Heart J 70(4): 376–81CrossRefPubMedGoogle Scholar
  56. 56.
    Niedt GW, Schinelle RA (1985) Acquired immunodeficiency syndrome. Clinicopathologic study of 56 autopsies. Arch Pathol Lab Med 109(8): 727–34PubMedGoogle Scholar
  57. 57.
    Rodriguez ER, Nasim S, Hsia J, Sandin RL, Ferreira A, Hilliard BA, Ross AM, Garrett CT (1991) Cardiac myocytes and dendritic cells harbor human immunodeficiency virus in infected patients with and without cardiac dysfunction: Detection by multiplex, nested, polymerase chain reaction in individually microdissected called from right ventricular endomyocardial biopsy tissue. Am J Cardiol 68(15): 1511–20CrossRefPubMedGoogle Scholar
  58. 58.
    Parrillo JE, Cunnion RE, Epstein SE, Parker MM, Suffredini AF, Brenner M, Schaer GL, Palmeri ST, Cannon RO, Alling D (1989) A prospective, randomized, controlled trial of prednisone for dilated cardiomyopathy. N Engl J Med 321(16): 1119–21CrossRefGoogle Scholar
  59. 59.
    McNamara DM, Holubkov R, Starling RC, Dec GW, Loh E, Torre-Amione G, Gass A, Janosko K, Tokarczyk T, Kessler P et al (2001) Controlled trial of intravenous immune globulin in recent-onset dilated cardiomyopathy. Circulation 103(18): 2254–9PubMedGoogle Scholar
  60. 60.
    Staudt A, Schäper F, Stangl V, Plagemann A, Bohm M, Merkel K, Wallukat G, Wernecke KD, Stangl K, Baumann G, Felix SB (2001) Immunohistological changes in dilated cardiomyopathy induces by immunoadsorption therapy and subsequent immunoglobulin substitution. Circulation 103(22): 2681–6PubMedGoogle Scholar

Copyright information

© Springer Basel 2010

Authors and Affiliations

  • Kenneth L. Baughman
    • 1
  1. 1.Advanced Heart Disease Section, Division of Cardiovascular MedicineBrigham and Women’s HospitalBostonUSA

Personalised recommendations